Health
Sold as a Natural Supplement, Kratom Is an Opioid, UVA Poison Expert Warns
Walk into some convenience stores, gas stations, or vape shops, and you may find products advertised as natural remedies for pain, anxiety, or low energy. Some are sold as powders, capsules, concentrated extracts, or tablets.
But according to a University of Virginia medical expert, one increasingly popular ingredient in these products carries risks that many consumers may not fully understand.
Kratom is an opioid, not simply a plant with opioid-like effects, says Dr. Christopher Holstege, an emergency medicine pediatrician at UVA Children’s and director of the Blue Ridge Poison Center.
In a recent interview with UVA Health’s Sonam Sheth, Holstege explained why he believes the substance should be recognized for its opioid activity and why its growing availability has become a serious public health concern.
“This is an opioid. It’s clearly an agonist at the opioid receptor,” Holstege said.
His concern goes beyond terminology. He says people using kratom may develop dependence, experience withdrawal symptoms, and suffer dangerous complications, including overdoses.
Poison Center Calls Have Increased Dramatically
One of the strongest indications of kratom’s growing impact comes from the nation’s poison centers.
A study involving UVA Health researchers examined kratom-related exposure reports submitted to U.S. poison centers between 2015 and 2025.
That’s an increase of approximately 1,200% in ten years.
During the full study period, poison centers recorded 14,449 kratom-related exposure reports. The research also identified 233 associated deaths, most involving more than one substance.
The findings, published in the Centers for Disease Control and Prevention’s Morbidity and Mortality Weekly Report, also documented substantial increases in hospitalizations involving kratom.
Poison center calls do not represent every exposure or establish how many people use kratom. However, the sharp increase raises concerns about the substance’s growing availability and the consequences of its use.
Holstege said the trend is continuing, with increasing numbers of patients appearing in emergency departments with complications involving kratom products.
“We have seen multiple cases come into the emergency department with overdoses. We’ve seen multiple people come in withdrawal,” he said.
Why Kratom Acts Like an Opioid
Kratom comes from a tropical tree native to Southeast Asia. Its leaves contain naturally occurring chemicals that affect the human body.
The most prominent is mitragynine, which acts on opioid receptors in the brain. The body can also convert mitragynine into another compound called 7-hydroxymitragynine, commonly known as 7-OH.
These opioid receptors are the same type targeted by drugs such as morphine and other opioid medications.
Holstege explained that opioids can differ significantly in how strongly they activate these receptors, but that does not change their basic pharmacological classification.
He also pointed to what happens when people use kratom regularly.
Some users develop cravings, need increasing amounts to achieve the same effect, and experience withdrawal symptoms when they stop.
Those are familiar characteristics of opioid dependence.
In an editorial titled Kratom Is an Opioid, published in the Journal of Clinical Psychopharmacology, Holstege and co-author Dr. Andrew Kolodny argue that describing kratom as merely “opioid-like” understates its pharmacological effects and potential risks.
The argument concerns how kratom should be understood and classified. It does not mean that all kratom products are currently regulated as controlled opioids under federal law.
The Risk of Addiction May Surprise Users
Some people begin using kratom because they believe it will help manage chronic pain, relieve anxiety, provide energy, or ease withdrawal from other opioids.
Holstege said there is not enough well-controlled clinical research to establish its safety and effectiveness for these purposes.
He acknowledged that a substance acting on opioid receptors could produce some pain relief. But he questioned whether kratom offers benefits that outweigh its risks, especially when compared with medications whose ingredients, dosages, and clinical effects have been more thoroughly studied.
The possibility of dependence is one of his greatest concerns.
Holstege described encountering patients, including college-age individuals, who began using kratom for pain or other reasons and later discovered they could not easily stop.
Someone developing dependence may begin taking larger amounts or using the substance more frequently.
When they try to quit, they may experience nausea, sweating, increased heart rate, cravings, and other withdrawal symptoms.
Those uncomfortable symptoms can encourage continued use, even when the individual wants to stop.
Holstege said there is no established timetable for how quickly dependence may develop. The risk can vary depending on the product, dosage, frequency of use, and concentration of active ingredients.
He is especially concerned about products packaged and marketed in ways that appeal to younger consumers.
Some Products Are Far More Potent Than Traditional Kratom
Not all products labeled as kratom contain the same ingredients or concentrations.
Traditional kratom leaf generally contains relatively small amounts of 7-hydroxymitragynine. However, manufacturers now sell concentrated extracts and products with much higher levels of the compound.
Holstege said 7-OH can be substantially more potent than morphine in certain pharmacological measurements. He also discussed newer compounds, including mitragynine pseudoindoxyl, that have powerful opioid activity.
These substances may be sold in concentrated tablets and other products that differ considerably from traditional kratom leaf preparations.
That distinction matters because consumers may not know exactly what they are purchasing or how strong it will be.
High-potency products can cause dangerous sedation, impaired judgment, slowed breathing, loss of consciousness, and overdose.
Holstege said some patients have required naloxone, the medication used to reverse opioid overdoses.
He also emphasized that kratom-related deaths have occurred, including cases where kratom compounds were implicated without other drugs being involved.
The risks may increase when kratom is combined with alcohol, prescription sedatives, or other opioids.
Why Calling Kratom “Natural” Can Be Misleading
Kratom is sometimes promoted as a botanical product, with comparisons to coffee because the kratom tree belongs to the same plant family.
Holstege strongly rejects the suggestion that this makes kratom comparable to an ordinary cup of coffee.
“There is no analogy with coffee,” he said.
He explained that kratom’s activity at opioid receptors, its potential to create dependence, and its connection to serious medical complications set it apart from ordinary caffeine consumption.
Plants can contain powerful drugs, he noted. The fact that a chemical occurs naturally does not automatically make it safe.
Another concern is quality control.
Unlike approved prescription medications, kratom products have not undergone the same testing to establish standardized doses, effectiveness, and safety for medical treatment.
The amount of active chemicals can vary widely between products, leaving consumers uncertain about what they are taking.
Federal Officials Are Examining Stronger Controls
The U.S. Food and Drug Administration has warned consumers about the dangers of concentrated 7-OH products.
The agency has taken enforcement action against certain products and recommended tighter restrictions on concentrated 7-OH because of its opioid effects and potential for abuse.
In October 2026, the U.S. Department of Justice announced updated federal scheduling proposals targeting concentrated 7-OH and several related synthetic opioid compounds.
Those efforts distinguish concentrated or chemically enhanced products from traditional kratom leaves containing only naturally occurring trace levels of 7-OH.
Holstege believes stronger oversight is needed as products become more widely available.
He expressed frustration that substances capable of producing opioid dependence and overdose can be purchased in ordinary retail settings without the safeguards generally associated with prescription opioid medications.
What Should Someone Do if They’re Using Kratom?
Holstege encourages anyone who believes they have developed a dependence on kratom to speak with a healthcare professional.
A primary care physician or addiction specialist can evaluate symptoms, discuss withdrawal concerns, and recommend appropriate treatment.
Medical treatments used for opioid use disorder may be considered in certain cases of kratom dependence, but those decisions should be made with a qualified clinician.
People should also avoid assuming that a product is safe simply because it is sold without a prescription or marketed as a supplement.
Anyone experiencing severe sedation, difficulty breathing, or loss of consciousness after taking kratom or a related product needs immediate emergency medical attention. Naloxone may help reverse opioid-related breathing problems, but emergency services should still be contacted.
For questions about kratom exposures or possible poisoning, the Blue Ridge Poison Center provides free, confidential guidance around the clock.
Blue Ridge Poison Center: 1-800-222-1222
The service is available 24 hours a day, seven days a week, with nurses and toxicology specialists on hand to help.
For Holstege, the growing number of poison center calls, emergency department visits, and families affected by kratom illustrates why he believes the public needs a clearer understanding of what these products can do.
He said the most difficult part of his work is speaking with families who have experienced serious harm or lost loved ones.
His message is that kratom should not be viewed as a harmless herbal alternative simply because it is readily available on store shelves.








